CD68 and hepatocellular carcinoma: Recent analysis of Genotype-Tissue Expression datasets (TCGA) and immunohistology have demonstrated that high expression of CD68 was correlated with worse prognosis in glioblastoma, renal clear cell carcinoma, lower-grade glioma, HCC, lung squamous cell carcinoma, thyroid carcinoma, and thymoma, but with favorable prognosis in chromophobe renal cell carcinoma (38).